Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concernSARS-CoV-2 Delta 변이체 감염은 우려되는 알파 또는 비 변이체에 비해 상기도에서 4배 증가된 바이러스 부하를 나타냅니다.Article Published on 2022-08-172022-09-11 Journal: Scientific Reports [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age all age group all age groups Alpha Alpha variant B.1.1.7 B.1.617.2 coronavirus Delta delta variant dominant Evidence evidenced genomic Genomic surveillance group groups in viral no difference Older age other variants reported respiratory sample Respiratory samples Sample size SARS-CoV-2 severe acute respiratory syndrome Coronavirus Sex significantly lower suggested Surveillance the SARS-CoV-2 Transmissibility upper airway vaccination variant variants Viral load viral loads Wuhan strain [DOI] 10.1038/s41598-022-18279-5 PMC 바로가기 [Article Type] Article
Nonpharmaceutical interventions against the COVID-19 pandemic significantly decreased the spread of enterovirus in childrenCOVID-19 대유행에 대한 비약물적 개입은 어린이의 엔테로바이러스 확산을 크게 줄였습니다Article Published on 2022-08-012022-09-11 Journal: Journal of medical virology [Category] Fulltext, MERS, 치료기술, [키워드] Adenovirus adenovirus infection adopted age all age group all age groups Antigen benefit children Children's Hospital China collected coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic distribution Frequency gastroenteritis Gastrointestinal infection highest incidence Infection Intervention measure Medicine much lower occurred Patient positive positive rate Prevalence Prevention and control proportion proportions Protective reduction in rotavirus School significantly Spread Transmission university was performed Zhejiang [DOI] 10.1002/jmv.27806 PMC 바로가기 [Article Type] Article
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong홍콩의 심각한 Omicron BA.2 발병에 대한 낮은 인구 면역의 기여Article Published on 2022-06-242022-09-11 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] Adults age all age groups collected Critical explained Fatality rate herd immunity Hong Kong Immunity lack monitoring much lower Neutralizing antibodies neutralizing antibody Older Older adults omicron Omicron variant outbreak population immunity Prevalence protective immunity risk Risk assessment SARS-CoV-2 variant SARS-CoV-2 variants sera seropositive Seroprevalence uptake rate vaccination variant virus [DOI] 10.1038/s41467-022-31395-0 PMC 바로가기 [Article Type] Article
Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan일본의 변종 알파에 의한 것으로 추정되는 COVID-19의 연령 의존적 위험Article Published on 2022-06-102022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age all age group all age groups Alpha Analysis Assessing Care caused conducted Continuous continuous monitoring coronavirus coronavirus disease COVID-19 COVID-19 case COVID-19 cases death decrease Descriptive analyses Descriptive analysis Diagnosis epidemiological group health center incidence increased risk individual Infection Japan Medical care medical resource Mutation Older Patient patients proportion risk SARS-CoV-2 secure severe acute respiratory syndrome Coronavirus Severe case severe cases severity statistical Statistical estimation strain Strains variant variant of concern with COVID-19 [DOI] 10.3389/fpubh.2022.837970 PMC 바로가기 [Article Type] Article
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccineSinopharm/BBIBP-CorV 백신에 대한 면역 반응의 지속성Article Published on 2022-06-012022-09-11 Journal: Immunity, Inflammation and Disease [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] ACE2 age all age groups angiotensin Angiotensin-converting enzyme antibody Antibody Response Antibody responses assays blocking antibodies Cell Cohort COVID-19 declined detectable determine Efficacy ELISPOT ELISpot assays enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Ex vivo group groups Hospitalization immune response immune responses Immunity individual individuals interferon gamma investigated Kinetics long term memory B memory B cell overlapping peptide peptides persistence Protein RBD receptor Receptor-binding domain remained response SARS-CoV-2 second dose severe disease Sinopharm Sinopharm/BBIBP-CorV Spike protein T cell T cell response T cell responses the RBD the receptor-binding domain the spike protein the vaccine total antibodies total antibody Vaccine Vaccines variants variants of concern virus were assessed were measured [DOI] 10.1002/iid3.621 PMC 바로가기 [Article Type] Article
Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain스페인의 광범위한 인구에서 COVID-19 잠금이 당뇨병 관리 및 후속 조치에 미치는 영향Article Published on 2022-06-012022-09-12 Journal: European Journal of Clinical Investigation [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] affected age all age groups analysed analysis of variance ANOVA change clinical setting Complete COVID-19 Deleterious diabete diabetes control evaluate evaluated Follow-up Gender General population glycaemic control greater groups HbA1c Impact individual individuals investigated lockdown Logistic regression analysis management measure not significantly different Older partial lockdown repeated measure retrospective Spain Spanish study period tested [DOI] 10.1111/eci.13771 PMC 바로가기 [Article Type] Article
Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 20212020년 12월부터 2021년 10월까지 독일의 연령대별 COVID-19 예방접종이 COVID-19 발병률, 입원 및 사망에 미치는 영향Article Published on 2022-05-092022-09-11 Journal: Vaccine [Category] 변종, [키워드] age all age group all age groups circulation Course Coverage COVID-19 COVID-19 incidence death declined ecological examined Germany group hospitalisation hospitalisations immunisation Impact incidence increase investigated lockdown restriction lockdown restrictions Measures morbidity morbidity and mortality National Public public health Surveillance surveillance data virus variant virus variants [DOI] 10.1016/j.vaccine.2022.04.002 PMC 바로가기 [Article Type] Article
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 VaccineBNT162b2 mRNA COVID-19 백신 2~3회 투여 후 SARS-CoV-2 변이체에 대한 중화 항체 반응 평가Article Published on 2022-05-022022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 95% CI Against age all age group all age groups assessment BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine booster booster vaccination cohort study conducted COVID-19 D614G variant delta variant dose group Immunity increase in induce Japanese Kobe lowest median age men Messenger RNA mRNA much higher Neutralizing antibodies neutralizing antibody Older age omicron Omicron variant other variant other variants outcome pandemic participant Participants physician Positive test positive test result recipient recipients response SARS-CoV-2 SARS-CoV-2 pandemic test results tested the SARS-CoV-2 the vaccine titer titers university vaccination Vaccine variant variants [DOI] 10.1001/jamanetworkopen.2022.10780 PMC 바로가기 [Article Type] Article
The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis의료 종사자의 돌발성 감염에 대한 세 번째 BNT162b2 백신의 효과: 코호트 분석Article Published on 2022-05-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 all age groups BNT162b2 BNT162b2 mRNA vaccine BNT162b2 vaccine booster booster dose Breakthrough infection breakthrough infections Care Cohort cohort analysis coronavirus coronavirus disease Coronavirus disease 2019 defined delta variant dose follow-up period HCW HCWs Health Health care Health care worker health care workers indicate infection rate infection rates infections initiated Jerusalem mass vaccination Ministry of Health protective effect Relative risk risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus significantly lower third dose two-dose regimen vaccination Vaccine vaccine dose variant [DOI] 10.1016/j.cmi.2022.01.019 PMC 바로가기 [Article Type] Article
Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational studyObservational Study Published on 2022-05-012022-10-04 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 유전자 메커니즘, 임상, [키워드] Adverse adverse event adverse events Adverse reaction AEs age all age groups analyzed AZD1222 BNT162b2 caution Characteristics Clinical characteristics Clinical symptoms complications conducted Control COVID-19 COVID-19 vaccination COVID-19 vaccines dose epidemiological event first dose Frequency individual JNJ-78436735 Korean Mild Mortality MOST mRNA-1273 occurred Occurrence Patient Pfizer-BioNTech prevention Reactions reported Research SARS-CoV-2 severe AE severity South Korea study period vaccination Vaccine vaccine reactions were assessed [DOI] 10.1016/j.ijid.2022.03.007 PMC 바로가기 [Article Type] Observational Study